Deep 6 AI expands executive lineup

By The Science Advisory Board staff writers

June 29, 2021 -- Artificial intelligence (AI)-based clinical trial software developer Deep 6 AI has appointed Chris Brubaker as chief marketing and customer officer and Talha Basit as chief technology officer.

Basit, who recently served as chief technology officer for online pharmacy DivvyDose, will be responsible for the firm's engineering, data, machine learning, and product teams, according to Deep 6 AI. Brubaker joins Deep 6 AI after a stint as vice president of marketing at Suki AI, a developer of AI digital assistants for physicians.

From lab to clinic: How AI can help
Clinical trials are an important checkpoint in moving therapies from the lab to the clinic, and artificial intelligence (AI) software can help researchers...

Copyright © 2021 scienceboard.net


Conferences
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter